Annual report
7446.TEDINET S100PTYB
Period2021-10-01 → 2022-09-30
Filed2022-12-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RSYI (2023-09-05).
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥37.3bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥36.2bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥31.0bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥31.0bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥31.7bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥944m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥713m | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.0bn | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥759m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥410m | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥330m | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥333m | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥975m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥748m | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥658m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥517m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥378m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥221m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥306m | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥681m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥538m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥17.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥16.1bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥14.6bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.8bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥9.8bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.7bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥5.4bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥5.3bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥799m | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥660m | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥730m | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥596m | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥886m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥322m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥441m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥765m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥335m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥92m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥172m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥205m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥143m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥122m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥186m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥221m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥511m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥15m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥209m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥728.76 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥564.91 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥404.57 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥236.3 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥326.18 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥7,330.63 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥6,829.86 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥6,023.38 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,693.08 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥5,637.31 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 37.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.0% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 10.2% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 321 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 316 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 314 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 309 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 329 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥28.4bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥27.8bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥24.4bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.3bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥24.6bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥792m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥591m | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥846m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥633m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥380m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥318m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥347m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥817m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥633m | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥547m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥424m | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥356m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥214m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥218m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥14.1bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥13.0bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥11.7bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.7bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.5bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥7.0bn | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥6.3bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥6.0bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥5.5bn | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥5.3bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.2bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥671m | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥606.07 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥463.89 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥380.41 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥228.09 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥232.82 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥115 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥105 | 2020-10-01 → 2021-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥90 | 2017-10-01 → 2018-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥6,987.67 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥6,615.32 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,917.64 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,610.97 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥5,564.01 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 44.7% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.4% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.4% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.9% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.9% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.3% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.6% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.1% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 960,000 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 960,000 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 960,000 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 960,000 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 960,000 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 236 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 230 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 228 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 226 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 232 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 33
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | employees | at 2022-09-30 | 6 pure |
| Otherother segments | revenue | 2021-10-01 → 2022-09-30 | ¥384m |
| Otherother segments | revenue external | 2021-10-01 → 2022-09-30 | ¥384m |
| Otherother segments | revenue external | 2021-10-01 → 2022-09-30 | ¥384m |
| Foodreportable segment | employees | at 2022-09-30 | 15 pure |
| Foodreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥3.3bn |
| Foodreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥3.3bn |
| Foodreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥3.3bn |
| Pharmaceutical Productsreportable segment | employees | at 2022-09-30 | 77 pure |
| Pharmaceutical Productsreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥18.0bn |
| Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥18.0bn |
| Pharmaceutical Productsreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥18.0bn |
| Reagent For Clinical Testreportable segment | employees | at 2022-09-30 | 69 pure |
| Reagent For Clinical Testreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥15.6bn |
| Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥15.6bn |
| Reagent For Clinical Testreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥37.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥37.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥37.3bn |
| Otherother segments | revenue | 2020-10-01 → 2021-09-30 | ¥417m |
| Otherother segments | revenue external | 2020-10-01 → 2021-09-30 | ¥417m |
| Foodreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥3.3bn |
| Foodreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥3.3bn |
| Pharmaceutical Productsreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥17.8bn |
| Pharmaceutical Productsreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥17.8bn |
| Reagent For Clinical Testreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥14.7bn |
| Reagent For Clinical Testreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-09-30 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-09-30 | ¥36.2bn |
| Otherother segments | employees | at 2022-09-30 | 2 pure |
| Foodreportable segment | employees | at 2022-09-30 | 8 pure |
| Pharmaceutical Productsreportable segment | employees | at 2022-09-30 | 63 pure |
| Reagent For Clinical Testreportable segment | employees | at 2022-09-30 | 29 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,654
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02810-000PharmaceuticalProductsReportableSegmentsMember | 77 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02810-000ReagentForClinicalTestReportableSegmentsMember | 69 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E02810-000FoodReportableSegmentsMember | 15 | |
| Number of employees | CurrentYearInstant_OtherReportableSegmentsMember | 6 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 154 | |
| Number of employees | CurrentYearInstant | 321 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 236 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 45.2 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 17.7 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 4874000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02810-000PharmaceuticalProductsReportableSegmentsMember | 63 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02810-000ReagentForClinicalTestReportableSegmentsMember | 29 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E02810-000FoodReportableSegmentsMember | 8 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_OtherReportableSegmentsMember | 2 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 134 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 236 | |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 254000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 960000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 960000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 960000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 960000 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 5 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 11 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 30 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 6 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 711 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 763 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1196 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 56 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 2194 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 6122 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 9588 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 1200 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.125 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.006 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.229 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.002 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.639 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 69600 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.077 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 50800 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.056 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |